Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Faculty of Tropical Medicine (FTM), Mahidol University, Thailand hosted a Congratulations party to honour Professor Sir Nicholas J. White, FRS, OBE on the occasion of his receiving Knight Commander of the Order of St. Michael and St. George from the United Kingdom for services to Tropical Medicine and Global Health.

On 14th February, the Faculty of Tropical Medicine (FTM), Mahidol University, Thailand hosted a Congratulations party to honour Professor Sir Nicholas J. White, FRS, OBE on the occasion of his receiving Knight Commander of the Order of St. Michael and St. George from the United Kingdom for services to Tropical Medicine and Global Health.

A Professor of Tropical Medicine at the University of Oxford (UK) and Mahidol University, a Fellow of St John's College and Chairman of the Wellcome Trust's South East Asian Research Units, Professor White's research interests include the pathophysiology and treatment of severe malaria, the prevention of antimalarial drug resistance using artemisinin-based combinations, and the biology of relapse in vivax malaria. He has lived and worked in Thailand for over 30 years.

After congratulatory speeches from FTM Dean Pratap Singhasivanon and MORU Director Professor Nicholas PJ Day, Professor White received a flower bouquet and souvenir from Dean Pratap. Held in the FTM’s Rajanakarindra Building, the event was well attended by Professor Sir Nick’s colleagues and members of the Faculty.

Similar stories

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

MORU Bangkok Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

Susie Dunachie awarded flagship NIHR career development award

Awards & Appointments MORU Bangkok

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand. Congratulations!

The COVID-19 vaccine: do we know enough to end the pandemic?

MORU Bangkok Research

Blog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.

New study on the risk of Plasmodium vivax parasitaemia after Plasmodium falciparum malaria

MORU Bangkok Publication Research

A new study quantifying the high risk of Plasmodium vivax parasitaemia after treatment of Plasmodium falciparum malaria aims to identify populations in which a policy of universal radical cure, combining artemisinin-based combination therapy with a hypnozoitocidal antimalarial drug, would be most beneficial.

Clare Ling awarded honorary FRCPath

Awards & Appointments SMRU

Dr Clare Ling has been made an honorary Fellow of the Royal College of Pathologists (FRCPath). Currently running Shoklo Malaria Research Unit (SMRU) Microbiology department and supporting the unit’s molecular activities, Clare is a clinical scientist who has worked at SMRU on the Thai-Myanmar border since 2012.

Applicability of COVID-19 vaccine trial results to low-and-middle-income countries

COVID-19 MORU Bangkok

In the next few months, the first Phase 3 COVID-19 vaccine trials – the majority of them in upper-middle or high-income countries and in specific target populations like young adults – will report their results. How relevant will their study results be for low-resource settings?